September 26, 2022
Albireo Signs Royalty Deal with $115 Million Upfront Payment
Read More
September 21, 2022
M&A and Partnering Deals Brighten August for Rare Disease Drug Developers
Read More
September 16, 2022
Benitec Raises $18 Million In Public Offering
Read More
September 15, 2022
Sarepta Prices $1 Billion Convertible Note Offering on Heels of FDA Lifting Hold on DMD Trial
Read More
September 15, 2022
Rhythm Pharmaceuticals Raises $125 Million in Public Offering
Read More
September 14, 2022
Capstan Therapeutics Launches with $165 Million to Develop In Vivo Cell Engineering Therapies
Read More
September 14, 2022
SparingVision raises $75 Million to Advance Portfolio of Genomic Medicines for Ocular Disease
Read More
September 14, 2022
Larimar Therapeutics Raises $70 Million After FDA Clears Full Clinical Hold on FA Therapy
Read More
September 13, 2022
Alnylam Announces Pricing of Offering of $900 Million Convertible Senior Notes
Read More
September 13, 2022
Solve FSHD Contributes $1 Million in Funding to n-Lorem for FSHD2 Collaboration
Read More
September 12, 2022
Pretzel Launches with $72.5 Million in Funding to Pioneer Mitochondrial Therapies
Read More
August 16, 2022
Fulcrum Raises $75 Million in Public Offering to Advance Rare Disease Pipeline
Read More
Load More
X